1. Home
  2. OLPX vs ORIC Comparison

OLPX vs ORIC Comparison

Compare OLPX & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olaplex Holdings Inc.

OLPX

Olaplex Holdings Inc.

HOLD

Current Price

$2.03

Market Cap

1.0B

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$10.26

Market Cap

837.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLPX
ORIC
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
837.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
OLPX
ORIC
Price
$2.03
$10.26
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$1.89
$19.73
AVG Volume (30 Days)
6.7M
2.4M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.67
EPS
N/A
N/A
Revenue
$422,960,000.00
N/A
Revenue This Year
$2.95
N/A
Revenue Next Year
$3.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.07
N/A
52 Week Low
$0.99
$4.52
52 Week High
$2.04
$14.93

Technical Indicators

Market Signals
Indicator
OLPX
ORIC
Relative Strength Index (RSI) 72.30 46.94
Support Level $1.20 $9.75
Resistance Level $2.04 $10.79
Average True Range (ATR) 0.01 1.03
MACD 0.01 0.04
Stochastic Oscillator 70.00 52.67

Price Performance

Historical Comparison
OLPX
ORIC

About OLPX Olaplex Holdings Inc.

Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: